| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation
|
Tziomalos, Konstantinos
|
|
2015
|
41 |
2 |
p. 336-342
|
artikel
|
| 2 |
Bleeding complications in venous thrombosis patients on well-managed warfarin
|
Sandén, Per
|
|
2015
|
41 |
2 |
p. 351-358
|
artikel
|
| 3 |
Decision-making about the use of non-vitamin K oral anticoagulant therapies for patients with atrial fibrillation
|
Eckman, Mark H.
|
|
2015
|
41 |
2 |
p. 234-240
|
artikel
|
| 4 |
Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy
|
Huang, Meng-jie
|
|
2015
|
41 |
2 |
p. 321-327
|
artikel
|
| 5 |
Impact of regular physical activity on weekly warfarin dose requirement
|
Rouleau-Mailloux, Étienne
|
|
2015
|
41 |
2 |
p. 328-335
|
artikel
|
| 6 |
Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication
|
Cuker, Adam
|
|
2015
|
41 |
2 |
p. 241-247
|
artikel
|
| 7 |
Measurement tools and antidotes for non-vitamin K oral anticoagulants
|
Becker, Richard C.
|
|
2015
|
41 |
2 |
p. 233
|
artikel
|
| 8 |
Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism
|
Klok, F. A.
|
|
2015
|
41 |
2 |
p. 312-320
|
artikel
|
| 9 |
Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study
|
Tamim, Hani
|
|
2015
|
41 |
2 |
p. 301-311
|
artikel
|
| 10 |
Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS)
|
Eicher, John D.
|
|
2015
|
41 |
2 |
p. 343-350
|
artikel
|
| 11 |
Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol
|
Kepplinger, Jessica
|
|
2015
|
41 |
2 |
p. 293-300
|
artikel
|
| 12 |
The biochemistry, enzymology and pharmacology of non-vitamin K anticoagulant drug reversal agents and antidotes
|
Becker, Richard C.
|
|
2015
|
41 |
2 |
p. 273-278
|
artikel
|
| 13 |
Universal, class-specific and drug-specific reversal agents for the new oral anticoagulants
|
Ansell, Jack E.
|
|
2015
|
41 |
2 |
p. 248-252
|
artikel
|
| 14 |
Who, when, and how to reverse non-vitamin K oral anticoagulants
|
Aronis, Konstantinos N.
|
|
2015
|
41 |
2 |
p. 253-272
|
artikel
|
| 15 |
Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?
|
Washam, Jeffrey B.
|
|
2015
|
41 |
2 |
p. 279-284
|
artikel
|
| 16 |
Widening the path and window of opportunity for FDA approval of non-vitamin K oral anticoagulant specific antidotes and reversal agents
|
Patel, Sunny
|
|
2015
|
41 |
2 |
p. 285-292
|
artikel
|
Tijdschrift beschrijving